Evidence map›Paper›PMID 41696580›Full record

ArticleFrontiers in molecular biosciences2026

Biophysical insights into recombinant Zeocin binding protein: conformational stability and folding dynamics across pH and temperature.

Sara Alharbi, Ajamaluddin Malik, Abdulaziz Alamri, Javed Masood Khan, Mohd Shahnawaz Khan, Abdullah Alhomida, Tauseef Ahmad

Abstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sara AlharbiDepartment of Biochemistry, Collage of Science, King Saud University, Riyadh, Saudi Arabia.
Ajamaluddin MalikDepartment of Biochemistry, Collage of Science, King Saud University, Riyadh, Saudi Arabia.
Abdulaziz AlamriDepartment of Biochemistry, Collage of Science, King Saud University, Riyadh, Saudi Arabia.
Javed Masood KhanDepartment of Food and Nutrition, Facility of Food and Agriculture Science, King Saud University, Riyadh, Saudi Arabia.
Mohd Shahnawaz KhanDepartment of Biochemistry, Collage of Science, King Saud University, Riyadh, Saudi Arabia.
Abdullah AlhomidaDepartment of Biochemistry, Collage of Science, King Saud University, Riyadh, Saudi Arabia.
Tauseef AhmadDepartment of Medical Education, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zeocin-binding protein (ZBP) confers resistance to the bleomycin family of antibiotics across a wide variety of prokaryotic and eukaryotic hosts. Zeocin is a bleomycin derivative used in cancer treatment. ZBP's mechanism involves binding to Zeocin, shielding DNA from damage. In protein folding studies, ZBP, a versatile marker across various organisms, can be used to track protein folding by fusing it to target proteins in prokaryotes and eukaryotes. Despite its significance, ZBP's biophysical properties are poorly studied. This study characterized the conformational changes, pH stability, solubility, and thermodynamic stability of recombinant ZBP from

Indexed as

bleomycincircular dichroismdynamic multimode spectroscopyfluorescencethermal stabilityzeocin

Identifiers

PMID41696580
PMCPMC12893952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.